Dry eye questionnaires capture only 22.4% of Demodex blepharitis symptoms, and a 22-study review links Demodex infestation to worse meibomian gland function.

Shane Kannarr, OD, overviews results from a phase 4, multicenter, prospective, open-label trial that evaluated the impact of concomitant use of PFHO during contact lens wear.

Real-world PFHO data show OSDI scores falling within 2 weeks, while a 12-month trial finds stable corneal endothelial cell density with cyclosporine 0.1%.

Christopher W. Lievens, OD, MS, PhD, FAAO, FNAP, FBCLA, discusses his poster presentation titled "Latanoprostene bunod 0.024% Initiation in Medicare Fee-for-Service Patients with Open Angle Glaucoma and Ocular Hypertension."

David Webley, BSc (Hons), MCOptom, FBCLA, weighs in on SightGlass Vision's latest data presented at AAOpt's annual meeting in Anaheim, California.

The company reported that Acuvue Oasys Max 1-Day and Oasys 1-Day outperformed the other 5 daily disposable lenses evaluated in a recent study, among other Johnson & Johnson data highlights at AAOpt 2026.

Three residents were honored for their leadership, education and research, and patient care contributions in ophthalmology, optometry, and retina.

DOT lenses reduce retinal contrast signaling through embedded light-scattering elements while maintaining a single power across the lens, rather than creating peripheral defocus with multiple optical powers.